fda warning letter compounded semaglutide september 2025 Semaglutide: The Drug of Today and a Steppingstone to Tomorrow FDA warns Ozempic and Mounjaro

To help consumers avoid losing their money and personal information to scammers, the BBB highlighted the most common GLP-1 and weight loss scams being circulated right now

The OpenLoop January 2026 breach did affect potential MEDVi patient records

Follow these guidelines to maximize freshness, safety, and reheating quality throughout the week: Store each component in a separate airtight container

GLP-1 RAs mimic the effects of GLP-1, an endogenous hormone that increases insulin secretion, regulates blood glucose levels, delays gastric emptying, and promotes satiety (Friedman, 2024)

Retatrutide 30mg is not intended for human consumption, veterinary use, self-administration, clinical use, treatment, diagnosis, prevention, cosmetic use, supplement use, body composition use, wellness use, weight-loss use or any form of personal use

No clinical efficacy or safety issues were raised and Citius stated it will continue working toward FDA approval of Lymphir